Keppra | Levetiracetam Injection, Solution, Concentrate while Breastfeeding
Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Keppra | Levetiracetam Injection, Solution, Concentrate.

What is Keppra | Levetiracetam Injection, Solution, Concentrate used for?


KEPPRA is indicated for adjunctive therapy, as an alternative when oral administration is temporarily not feasible, in the treatment of: Partial onset seizures in patients 1 month of age and older with epilepsy (1.1) Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3) 1.1 Partial Onset Seizures KEPPRA is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. KEPPRA injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy KEPPRA is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. KEPPRA injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible. 1.3 Primary Generalized Tonic-Clonic Seizures KEPPRA is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. KEPPRA injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.

Is Keppra | Levetiracetam Injection, Solution, Concentrate safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Keppra | Levetiracetam Injection, Solution, Concentrate safe for breastfeeding
Levetiracetam is the only one ingredient used in manufacturing of Keppra | Levetiracetam Injection, Solution, Concentrate, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Levetiracetam it is safe to use Keppra | Levetiracetam Injection, Solution, Concentrate while lactating. We suggest you to check further details below about Levetiracetam usage in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Levetiracetam is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from KEPPRA, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Keppra | Levetiracetam Injection, Solution, Concentrate Breastfeeding Analsys


Levetiracetam while Breastfeeding

Safe

CAS Number: 102767-28-2

Piracetam analog with nootropic and anti-epileptic effect. Authorized for use in children in Europe. Excreted into breast milk but infant serum levels were shown to be low. No other side effect than one case of hypotonia in a 7 days old premature whose mother was also on anti-epileptic medication. Seizures along with neonatal abstinence syndrome in a botlle fed neonate whose mother had taken Levetiracetam and Phenobarbital in pregnancy ocurred. Symptoms disappeared after initiation of breastfeeding.

Keppra | Levetiracetam Injection, Solution, Concentrate Breastfeeding Analsys - 2


Levetiracetam while Breastfeeding

CAS Number: 102767-28-2

Maternal doses of levetiracetam up to 3500 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. If levetiracetam is required by the mother, it is not a reason to discontinue breastfeeding. However, the infant should be monitored for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Maternal serum level monitoring and dosage adjustment is advisable in the early postpartum period if the drug was taken throughout pregnancy and breastfeeding.[1] Some evidence suggests that levetiracetam might reduce the maternal breastmilk supply in some women.


I already used Keppra | Levetiracetam Injection, Solution, Concentrate and meanwhile I breastfed my baby should I be concerned?

Keppra | Levetiracetam Injection, Solution, Concentrate is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Keppra | Levetiracetam Injection, Solution, Concentrate you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My health care provider has asked me to use Keppra | Levetiracetam Injection, Solution, Concentrate, what to do?

Usage of Keppra | Levetiracetam Injection, Solution, Concentrate is safe for nursing mothers and baby, No worries.


If I am using Keppra | Levetiracetam Injection, Solution, Concentrate, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Keppra | Levetiracetam Injection, Solution, Concentrate in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Spritam | Levetiracetam Tablet, For Suspension
Levetiracetam Injection Injection, Solution, Concentrate
Roweepra Xr | Levetiracetam Tablet, Extended Release